Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Corticosteroid for Post Extubation Stridor in Children
NCT02523820Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jan 2015
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in post-extubation stridor (PES), sponsored by Ramathibodi Hospital. Started Jan 2015; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
post-extubation stridor (PES)
Beyond the preview
Go deeper on NCT02523820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523820.